Search clinical trials for: AT-406 in combination with daunorubicin and cytarabine
Total 507 results
-
Ascenta TherapeuticsThe Leukemia and Lymphoma SocietyTerminated
-
Aarhus University HospitalVIA University College; Institute of public health, department of nursing sciences...Terminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 10-19 Percent of Bone Marrow Nucleated Cells and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Acute Myeloid Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Persistent DiseaseUnited States
-
Roswell Park Cancer InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Gene MutationsUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 | Myeloid NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Acute Myeloid Leukemia With Multilineage Dysplasia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Aileron Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Ohio State University Comprehensive Cancer CenterIncyte Corporation; Jazz PharmaceuticalsRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Secondary Acute Myeloid Leukemia | Myeloproliferative NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterUniversity of California, Los Angeles; Pfizer; Jazz PharmaceuticalsTerminatedAcute Myelogenous LeukemiaUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
Peking Union Medical CollegeNot yet recruiting
-
Shen LinUnknownColorectal Cancer | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancer | Targeted Therapy | HER2China
-
National Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | Acute Myeloid Leukemia Post Cytotoxic Therapy | Acute Myeloid Leukemia, Myelodysplasia-Related
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Henan Cancer HospitalRecruitingMetastatic Gastroesophageal Junction AdenocarcinomaChina
-
Tang-Du HospitalCompletedSintilimab and Anlotinib in Combination With ChemotherapyChina
-
Compugen LtdRecruitingMultiple Myeloma | Ovarian Cancer | Lung Cancer | Advanced Cancer | Colon Cancer | Plasma Cell Neoplasm | HNSCC | Microsatellite Stable Colorectal Carcinoma | MSS-CRCUnited States
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
The First Affiliated Hospital of Nanchang UniversityActive, not recruitingHelicobacter Pylori InfectionChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdTerminatedAcute Myeloid Leukemia (AML)China
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Leiden University Medical CenterRecruitingCannabis Use | Opioid Use | Respiratory DepressionNetherlands
-
Case Comprehensive Cancer CenterRecruitingMyelodysplastic Syndrome (MDS)United States
-
Cytos Biotechnology AGCompletedHouse Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
-
Treace Medical Concepts, Inc.RecruitingHallux Valgus | Metatarsus AdductusUnited States
-
National Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome
-
Jonsson Comprehensive Cancer CenterJazz PharmaceuticalsActive, not recruiting
-
Rondeep BrarNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
Shanghai Junshi Bioscience Co., Ltd.WithdrawnPrimary Condition: Advanced TumorsChina
-
Technische Universität DresdenPfizer; Novartis PharmaceuticalsRecruiting
-
InxMed (Shanghai) Co., Ltd.RecruitingPlatinum-resistant Ovarian CancerChina
-
Hospital Galdakao-UsansoloDepartment of Health, Basque Country, SpainUnknown
-
University of Kansas Medical CenterPenumbra Inc.CompletedAcute Deep Vein ThrombosisUnited States
-
S.LAB (SOLOWAYS)NMSI DENTMASTERNot yet recruiting
-
University of BolognaCompagnia di San PaoloCompleted
-
Jiangsu Simcere Biologics Co., LtdRecruitingAdvanced Solid Tumor | Cutaneous T Cell LymphomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
The European Research Group on Periodontology (ERGOPerio)The University of Hong KongCompletedGingival RecessionHong Kong
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
National Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm | Acute Myeloid Leukemia Post Cytotoxic Therapy
-
GenmabBioNTech SEActive, not recruitingCervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Solid Tumors | Endometrial Carcinoma | Urothelial CarcinomaUnited States, Spain, Israel, Czechia, Georgia, Italy, Poland, Turkey, Hungary, Ukraine
-
Regor Pharmaceuticals Inc.Recruiting
-
Sir Run Run Shaw HospitalHangzhou Neoantigen Therapeutics Co., Ltd.RecruitingDigestive System NeoplasmsChina